Clinical Trial

Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis

Name: Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis — clinical trial record (NCT07347626)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: E-TWIST

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, open-label, blinded-endpoint clinical trial designed to evaluate the efficacy and safety of early administration of eptifibatide following intravenous thrombolysis in patients with acute ischemic stroke who present 4.5 to 24 hours after symptom onset.

Trial Details

NCT Number	NCT07347626
Lead Sponsor	Xinqiao Hospital of Chongqing Collaborators: The First Affiliated Hospital of Hainan Medical University, The First Affiliated Hospital of Nanchang University
Conditions	Acute Ischemic Stroke
Enrollment	786 participants
Start Date	2026-03-01
Primary Completion	2029-09-30 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-16